Shuangshuang Wen1, Huimin Xiao2, Yanqing Yang1. 1. School of Nursing, Fujian Medical University, No 1 Xuefu North Road, University Town, Shangjie Zhen, Minhou County, Fuzhou City, 350122, Fujian Province, China. 2. School of Nursing, Fujian Medical University, No 1 Xuefu North Road, University Town, Shangjie Zhen, Minhou County, Fuzhou City, 350122, Fujian Province, China. huimin_xiao@126.com.
Abstract
PURPOSE: This systematic review aims to identify the risk factors for depression in cancer patients undergoing chemotherapy. METHODS: Eight electronic databases were searched from inception of the databases established until August 2017. References for the included studies were retrieved by manual searching. The quality of the eligible studies was appraised by two persons using the 11-item checklist of the Agency for Healthcare Research and Quality (AHRQ). RESULTS: Among 5988 potentially relevant articles, 43 studies were eligible, with 17 studies of high quality and 25 studies of moderate quality. A total of 65 factors were extracted, including sociodemographic characteristics (n = 20), physiological condition (n = 20), disease and treatment (n = 12), and psychosocial factors (n = 13). Only social support, anxiety, perceived stress, and self-efficacy were found to be consistently associated with depression in cancer patients. There is not enough evidence to support the link between the other 61 factors and depression in cancer patients undergoing chemotherapy. CONCLUSIONS: This review suggests that the development of depression programs should take social support, anxiety, perceived stress, and self-efficacy into account. More original studies with rigorous design are necessary to further confirm those 61 inconclusive risk factors for depression in cancer patients receiving chemotherapy.
PURPOSE: This systematic review aims to identify the risk factors for depression in cancerpatients undergoing chemotherapy. METHODS: Eight electronic databases were searched from inception of the databases established until August 2017. References for the included studies were retrieved by manual searching. The quality of the eligible studies was appraised by two persons using the 11-item checklist of the Agency for Healthcare Research and Quality (AHRQ). RESULTS: Among 5988 potentially relevant articles, 43 studies were eligible, with 17 studies of high quality and 25 studies of moderate quality. A total of 65 factors were extracted, including sociodemographic characteristics (n = 20), physiological condition (n = 20), disease and treatment (n = 12), and psychosocial factors (n = 13). Only social support, anxiety, perceived stress, and self-efficacy were found to be consistently associated with depression in cancerpatients. There is not enough evidence to support the link between the other 61 factors and depression in cancerpatients undergoing chemotherapy. CONCLUSIONS: This review suggests that the development of depression programs should take social support, anxiety, perceived stress, and self-efficacy into account. More original studies with rigorous design are necessary to further confirm those 61 inconclusive risk factors for depression in cancerpatients receiving chemotherapy.
Authors: Christopher Fagundes; Desiree Jones; Elisabeth Vichaya; Charles Lu; Charles S Cleeland Journal: J Thorac Oncol Date: 2014-10 Impact factor: 15.609
Authors: Cristiane Decat Bergerot; Karen Lynn Clark; Alexandre Nonino; Sarah Waliany; Marco Murilo Buso; Matthew Loscalzo Journal: Palliat Support Care Date: 2013-11-04
Authors: Vivian E von Gruenigen; Jessica R Hutchins; Anne Marie Reidy; Heidi E Gibbons; Barbara J Daly; Elisa M Eldermire; Nancy L Fusco Journal: Health Qual Life Outcomes Date: 2006-10-30 Impact factor: 3.186
Authors: Cristiano Scandurra; Francesco Mangiapia; Roberto La Rocca; Francesco Di Bello; Natascia De Lucia; Benedetta Muzii; Micaela Cantone; Rita Zampi; Gianluigi Califano; Nelson Mauro Maldonato; Nicola Longo Journal: Support Care Cancer Date: 2022-05-18 Impact factor: 3.359
Authors: Claire L Niedzwiedz; Lee Knifton; Kathryn A Robb; Srinivasa Vittal Katikireddi; Daniel J Smith Journal: BMC Cancer Date: 2019-10-11 Impact factor: 4.430
Authors: Eveline van Montfort; Jolanda de Vries; Rita Arts; Joachim G Aerts; Jeroen S Kloover; Marjan J Traa Journal: Support Care Cancer Date: 2019-07-01 Impact factor: 3.603
Authors: Clara Breidenbach; Paula Heidkamp; Kati Hiltrop; Holger Pfaff; Anna Enders; Nicole Ernstmann; Christoph Kowalski Journal: BMC Psychiatry Date: 2022-02-09 Impact factor: 3.630